Avalo Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
10.63
|
|
Average Rating
|
4.25
|
|
# Strong Buys
|
2
|
|
# Buys
|
1
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.09
|
0.34
|
1.43
|
131.19%
|
|
2022-06-30
|
-1.77
|
-1.38
|
0.39
|
22.03%
|
|
2022-03-31
|
-1.60
|
-2.40
|
-0.80
|
-50.00%
|
|
2021-12-31
|
-1.90
|
-1.92
|
-0.02
|
-1.05%
|
|
2021-09-30
|
-2.16
|
-2.04
|
0.12
|
5.56%
|
|
2021-06-30
|
-2.04
|
-2.16
|
-0.12
|
-5.88%
|
|
2021-03-31
|
-2.32
|
-3.84
|
-1.52
|
-65.52%
|
|
2020-12-31
|
-1.80
|
-2.16
|
-0.36
|
-20.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-3.44
|
|
2021-12-31
|
-9.96
|
|
2020-12-31
|
-6.82
|
|
2019-12-31
|
-0.28
|
|
2018-12-31
|
-0.64
|
|
2016-12-31
|
-1.88
|
|
2015-12-31
|
-0.61
|